subject area of
- ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis? Academic Article
- Acute Generalized Exanthematous Pustulosis Induced by Hydroxychloroquine: First Case Report in Canada and Review of the Literature Academic Article
- Antithrombotic Drugs Academic Article
- Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Academic Article
- Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. Academic Article
- Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Academic Article
- Hydroxychloroquine attenuates cigarette smoke induced autophagic signaling in the mouse ovary Academic Article
- Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent Academic Article
- PLATELET SUPPRESSIVE THERAPY Academic Article
- Platelet inhibitors in the treatment of thrombosis. Academic Article
- Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease Academic Article
- The current status of platelet suppressive drugs in the treatment of thrombosis. Academic Article
- The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas—a randomized trial Academic Article
- The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus Academic Article
- Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases Academic Article
- What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies? Academic Article